Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Historical Holders from Q3 2024 to Q3 2025

Symbol
GRCE on Nasdaq
CUSIP
00439U104
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
14.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
3.71M
Holdings value
$11M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
20
Number of buys
6
Number of sells
-5
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 9.99% 0% $4.2M $36.7K 1.4M +0.88% Nantahala Capital Management, LLC Jun 30, 2025
HIRSCHMAN ORIN 9.9% +96% $2.45M $1.48M 1.32M +154% HIRSCHMAN ORIN Mar 31, 2025

Institutional Holders of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3.71M $11M -$328K $2.98 20
2025 Q2 3.82M $11.3M -$608K $2.97 20
2025 Q1 4.02M $9.17M +$4.41M $2.28 17
2024 Q4 2.09M $7.84M +$4.25M $3.74 15
2024 Q3 960K $2.88M +$2.88M $3.00 1